FDA Inspection 1088933 — Pfizer Clinical Research Unit, Hopital Erasme
The FDA completed an inspection of Pfizer Clinical Research Unit, Hopital Erasme on April 12, 2019 in Anderlecht. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Anderlecht (Belgium)
Additional Details
Clinical BA/BE